Decision Diagnostics Corp. (DECN)
USD 0.0
(0.0%)
USD 0.0
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2022 | - USD | 0.0% |
| 2021 | - USD | -100.0% |
| 2020 | 498.45 Thousand USD | -41.38% |
| 2019 | 850.35 Thousand USD | 176.81% |
| 2018 | 307.19 Thousand USD | 541.0% |
| 2017 | -69.65 Thousand USD | -128.0% |
| 2016 | 248.76 Thousand USD | 47.14% |
| 2015 | 169.06 Thousand USD | 0.0% |
| 2012 | 1.52 Million USD | -47.04% |
| 2011 | 2.87 Million USD | 75.73% |
| 2010 | 1.63 Million USD | 3.61% |
| 2009 | 1.57 Million USD | 6.84% |
| 2008 | 1.47 Million USD | 261.94% |
| 2007 | 408.49 Thousand USD | 1100.47% |
| 2006 | 34.02 Thousand USD | -93.22% |
| 2005 | 501.68 Thousand USD | 175.48% |
| 2004 | 182.11 Thousand USD | 140.21% |
| 2003 | 75.81 Thousand USD | 3690.65% |
| 2002 | 2000.00 USD | -99.44% |
| 2001 | 358.47 Thousand USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 Q1 | - USD | 0.0% |
| 2023 Q3 | - USD | 0.0% |
| 2023 Q2 | - USD | 0.0% |
| 2022 Q4 | - USD | 0.0% |
| 2022 FY | - USD | 0.0% |
| 2022 Q3 | - USD | 0.0% |
| 2021 FY | - USD | -100.0% |
| 2021 Q2 | 134.71 Thousand USD | 24.64% |
| 2021 Q3 | 115.27 Thousand USD | -14.43% |
| 2021 Q1 | 108.08 Thousand USD | 3.77% |
| 2020 FY | 498.45 Thousand USD | -41.38% |
| 2020 Q1 | 198.2 Thousand USD | -53.69% |
| 2020 Q2 | 100.11 Thousand USD | -49.49% |
| 2020 Q3 | 95.97 Thousand USD | -4.13% |
| 2020 Q4 | 104.15 Thousand USD | 8.52% |
| 2019 Q4 | 428.04 Thousand USD | 243.99% |
| 2019 Q3 | 124.43 Thousand USD | -0.29% |
| 2019 FY | 850.35 Thousand USD | 176.81% |
| 2019 Q2 | 124.79 Thousand USD | -33.56% |
| 2019 Q1 | 187.83 Thousand USD | -34.59% |
| 2018 Q1 | 212.83 Thousand USD | 235.69% |
| 2018 Q4 | 287.15 Thousand USD | 64.51% |
| 2018 FY | 307.19 Thousand USD | 541.0% |
| 2018 Q2 | 105.72 Thousand USD | -50.32% |
| 2018 Q3 | 174.55 Thousand USD | 65.09% |
| 2017 Q2 | 129.94 Thousand USD | 29.26% |
| 2017 Q1 | 100.52 Thousand USD | -53.07% |
| 2017 FY | -69.65 Thousand USD | -128.0% |
| 2017 Q4 | -156.85 Thousand USD | -210.02% |
| 2017 Q3 | 142.56 Thousand USD | 9.72% |
| 2016 Q3 | 54.25 Thousand USD | 173.9% |
| 2016 FY | 248.76 Thousand USD | 47.14% |
| 2016 Q4 | 214.21 Thousand USD | 294.86% |
| 2016 Q2 | -73.4 Thousand USD | -241.2% |
| 2016 Q1 | 51.98 Thousand USD | -47.63% |
| 2015 Q2 | 86.32 Thousand USD | 232.71% |
| 2015 Q4 | 99.27 Thousand USD | 22.57% |
| 2015 Q3 | 80.99 Thousand USD | -6.18% |
| 2015 Q1 | 25.94 Thousand USD | 0.0% |
| 2015 FY | 169.06 Thousand USD | 0.0% |
| 2014 Q2 | -58.64 Thousand USD | -201.21% |
| 2014 Q1 | 57.94 Thousand USD | 0.0% |
| 2013 Q3 | 230.41 Thousand USD | 479.43% |
| 2013 Q2 | 39.76 Thousand USD | -89.8% |
| 2013 Q1 | 390 Thousand USD | 995.15% |
| 2012 Q4 | 35.61 Thousand USD | -92.51% |
| 2012 Q2 | 538.88 Thousand USD | 14.01% |
| 2012 Q3 | 475.51 Thousand USD | -11.76% |
| 2012 Q1 | 472.64 Thousand USD | -38.81% |
| 2012 FY | 1.52 Million USD | -47.04% |
| 2011 Q4 | 772.43 Thousand USD | -20.14% |
| 2011 Q2 | 854.35 Thousand USD | 181.66% |
| 2011 Q1 | 303.32 Thousand USD | 31.44% |
| 2011 FY | 2.87 Million USD | 75.73% |
| 2011 Q3 | 967.25 Thousand USD | 13.21% |
| 2010 Q2 | 537.42 Thousand USD | 38.51% |
| 2010 Q3 | 482.23 Thousand USD | -10.27% |
| 2010 FY | 1.63 Million USD | 3.61% |
| 2010 Q4 | 230.77 Thousand USD | -52.15% |
| 2010 Q1 | 388.01 Thousand USD | -39.75% |
| 2009 Q2 | 348.12 Thousand USD | 25.89% |
| 2009 Q3 | 310.97 Thousand USD | -10.67% |
| 2009 Q4 | 644.03 Thousand USD | 107.1% |
| 2009 FY | 1.57 Million USD | 6.84% |
| 2009 Q1 | 276.53 Thousand USD | -42.45% |
| 2008 Q2 | 344.63 Thousand USD | -22.99% |
| 2008 Q4 | 480.48 Thousand USD | 133.36% |
| 2008 Q3 | 205.9 Thousand USD | -40.25% |
| 2008 Q1 | 447.49 Thousand USD | 359.64% |
| 2008 FY | 1.47 Million USD | 261.94% |
| 2007 Q4 | -172.35 Thousand USD | -166.8% |
| 2007 Q3 | 258.02 Thousand USD | 101.27% |
| 2007 Q2 | 128.19 Thousand USD | -34.13% |
| 2007 Q1 | 194.63 Thousand USD | 122.97% |
| 2007 FY | 408.49 Thousand USD | 1100.47% |
| 2006 Q2 | 167.34 Thousand USD | -74.61% |
| 2006 Q3 | 54.9 Thousand USD | -67.19% |
| 2006 Q4 | -847.32 Thousand USD | -1643.23% |
| 2006 FY | 34.02 Thousand USD | -93.22% |
| 2006 Q1 | 659.1 Thousand USD | 1487.66% |
| 2005 Q1 | 196.64 Thousand USD | 19486.55% |
| 2005 Q2 | 209.69 Thousand USD | 6.63% |
| 2005 Q4 | 41.51 Thousand USD | -22.87% |
| 2005 Q3 | 53.82 Thousand USD | -74.33% |
| 2005 FY | 501.68 Thousand USD | 175.48% |
| 2004 FY | 182.11 Thousand USD | 140.21% |
| 2004 Q3 | 51.67 Thousand USD | -10.22% |
| 2004 Q2 | 57.55 Thousand USD | 3.9% |
| 2004 Q1 | 55.39 Thousand USD | 8.37% |
| 2004 Q4 | 1004.00 USD | -98.06% |
| 2003 Q3 | 22.84 Thousand USD | 1592.44% |
| 2003 Q1 | 500.00 USD | 12.36% |
| 2003 Q2 | 1350.00 USD | 170.0% |
| 2003 FY | 75.81 Thousand USD | 3690.65% |
| 2003 Q4 | 51.11 Thousand USD | 123.72% |
| 2002 Q2 | 674.00 USD | -99.11% |
| 2002 Q4 | 445.00 USD | -11.0% |
| 2002 Q3 | 500.00 USD | -25.82% |
| 2002 FY | 2000.00 USD | -99.44% |
| 2002 Q1 | 75.77 Thousand USD | 0.0% |
| 2001 FY | 358.47 Thousand USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Alternative Energy Partners, Inc. | - USD | NaN% |
| Allstar Health Brands, Inc. | - USD | NaN% |
| Beijing Tong Ren Tang Chinese Medicine Company Limited | 134.07 Million USD | 100.0% |
| Café Serendipity Holdings, Inc. | 1196.00 USD | 100.0% |
| Health Advance Inc. | - USD | NaN% |
| HealthWarehouse.com, Inc. | 12.17 Million USD | 100.0% |
| LIGAND PHARMACEUTICAL INC | 88.02 Million USD | 100.0% |
| MedGen, Inc. | 1.05 USD | 100.0% |
| Omni Health, Inc. | 1.55 Million USD | 100.0% |
| Oxford Investments Holdings Inc. | 31.45 Thousand USD | 100.0% |
| Pineapple, Inc. | -1.02 Million USD | 100.0% |
| ScripsAmerica, Inc. | 27.59 Million USD | 100.0% |